Work

216PD: nab-Paclitaxel + carboplatin (nab-P/C) in advanced non-small cell lung cancer (NSCLC): outcomes in elderly patients (pts) with squamous (SCC) histology

Year: 2016

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/s1556-0864(16)30329-x

Authors: C. Gridelli, A. Ko, M. O'Brien, T.J. Ong, M.A. Socinski, P.E. Postmus

Institutions: Azienda Ospedaliera S.Giuseppe Moscati, Celgene (United States), Royal Marsden Hospital, University of Pittsburgh, Clatterbridge Cancer Centre NHS Foundation Trust

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Pfizer, AstraZeneca, Dana-Farber Cancer Institute, Astellas Pharma, Chugai Pharmaceutical

OpenAlex ID: W2341740814

FWCI: 0.598

Cites:

Cited by: 2

Related to: 10